Literature DB >> 17005800

Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages.

A R Gomes1, H Westh, H de Lencastre.   

Abstract

Most methicillin-resistant Staphylococcus aureus (MRSA) isolates identified among blood isolates collected in Denmark between 1957 and 1970 belonged to either phage group III or the closely related 83A complex and had a PSTM antibiotype (resistance to penicillin [P], streptomycin [S], tetracycline [T], and methicillin [M]). Recently, some of these isolates were shown to have the same genetic backgrounds as contemporary epidemic MRSA isolates, and Danish methicillin-susceptible S. aureus (MSSA) isolates from the 1960s with a PST antibiotype were proposed to have been the recipients of the mecA gene in those lineages. In this study, we investigated the genetic backgrounds of isolates from the 83A complex that were fully susceptible or resistant to penicillin only in order to try to trace the evolutionary trajectory of contemporary MRSA lineages. We also studied MSSA and MRSA isolates from other phage groups in order to investigate if they had the potential to develop into contemporary MRSA clones. Most susceptible or penicillin-resistant isolates from phage group III or the 83A complex belonged to sequence type 8 (ST8) or ST5, while four isolates were ST254. STs 30, 45 and 25 were represented by MSSA isolates from other phage groups, which also included several singletons. Representatives of most of the current major epidemic MRSA lineages were identified among fully susceptible isolates collected in the 1960s, suggesting that these were MSSA lineages which carried genetic traits important for superior epidemicity before the acquisition of methicillin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005800      PMCID: PMC1610072          DOI: 10.1128/AAC.00521-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals.

Authors:  W Witte; C Braulke; C Cuny; D Heuck; M Kresken
Journal:  Infect Control Hosp Epidemiol       Date:  2001-11       Impact factor: 3.254

2.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece.

Authors:  M Aires de Sousa; C Bartzavali; I Spiliopoulou; I Santos Sanches; M I Crisóstomo; H de Lencastre
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Analysis of the genetic variability of virulence-related loci in epidemic clones of methicillin-resistant Staphylococcus aureus.

Authors:  A R Gomes; S Vinga; M Zavolan; H de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  A new epidemic phage type of Staphylococcus aureus. I. The experimental typing phage 6557'.

Authors:  P Bülow
Journal:  Acta Pathol Microbiol Scand       Date:  1968

6.  Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia.

Authors:  O Jessen; K Rosendal; P Bülow; V Faber; K R Eriksen
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

7.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

8.  Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease.

Authors:  A Holmes; M Ganner; S McGuane; T L Pitt; B D Cookson; A M Kearns
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

9.  Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital.

Authors:  M A Dominguez; H de Lencastre; J Linares; A Tomasz
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil.

Authors:  L A Teixeira; C A Resende; L R Ormonde; R Rosenbaum; A M Figueiredo; H de Lencastre; A Tomasz
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  29 in total

1.  Restriction modification (RM) tests associated to additional molecular markers for screening prevalent MRSA clones in Brazil.

Authors:  C O Beltrame; A M N Botelho; M C Silva-Carvalho; R R Souza; R R Bonelli; M S Ramundo; M A Guimarães; L R Coelho; A M S Figueiredo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-13       Impact factor: 3.267

2.  Genetic diversity of methicillin-resistant Staphylococcus aureus in a tertiary hospital in The Netherlands between 2002 and 2006.

Authors:  E Nulens; E E Stobberingh; E Smeets; H van Dessel; M A Welling; S Sebastian; F H van Tiel; P S Beisser; R H Deurenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 3.267

3.  Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus.

Authors:  Ulrich Nübel; Philippe Roumagnac; Mirjam Feldkamp; Jae-Hoon Song; Kwan Soo Ko; Yhu-Chering Huang; Geoffrey Coombs; Margaret Ip; Henrik Westh; Robert Skov; Marc J Struelens; Richard V Goering; Birgit Strommenger; Annette Weller; Wolfgang Witte; Mark Achtman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-04       Impact factor: 11.205

4.  Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Davida S Smyth; Bo Shopsin; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

5.  Population structure of methicillin-susceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011).

Authors:  A Tavares; N A Faria; H de Lencastre; M Miragaia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-21       Impact factor: 3.267

Review 6.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

7.  High heterogeneity within methicillin-resistant Staphylococcus aureus ST398 isolates, defined by Cfr9I macrorestriction-pulsed-field gel electrophoresis profiles and spa and SCCmec types.

Authors:  M A Argudín; A Fetsch; B-A Tenhagen; J A Hammerl; S Hertwig; J Kowall; M R Rodicio; A Käsbohrer; R Helmuth; A Schroeter; M C Mendoza; J Bräunig; B Appel; B Guerra
Journal:  Appl Environ Microbiol       Date:  2009-12-18       Impact factor: 4.792

Review 8.  Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power.

Authors:  Herminia de Lencastre; Duarte Oliveira; Alexander Tomasz
Journal:  Curr Opin Microbiol       Date:  2007-10-24       Impact factor: 7.934

9.  Clonal complexes and diversity of exotoxin gene profiles in methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from patients in a Spanish hospital.

Authors:  M A Argudín; M C Mendoza; F J Méndez; M C Martín; B Guerra; M R Rodicio
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948

10.  Staphylococcal interspersed repeat unit typing of Staphylococcus aureus: evaluation of a new multilocus variable-number tandem-repeat analysis typing method.

Authors:  Teresa Conceição; Marta Aires de Sousa; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.